Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers: Guidance for Industry and Review Staff
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Administrative / Procedural
Published
June 13, 2018
Last updated
November 12, 2024
Description
This document is a guidance for drug and device manufacturers on their communications with payors and formulary committees.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)